Clinical Trial

A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.

Study acronym: NEOPILI-2A
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated June 8, 2025 (before its estimated August 14, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will evaluate the safety and efficacy of PDFE-2304 compared with Minoxidil 5% in men with androgenic alopecia (AGA).
Trial Details
NCT Number NCT07011485
Lead Sponsor PDFE Pharma Innovations FZCO
Conditions Alopecia, Androgenetic, Baldness, Androgenetic Alopecia (AGA)
Enrollment 15 participants
Start Date 2025-05-14
Primary Completion 2025-08-14 (estimated)
Study Completion 2025-09-17 (estimated)
Updated on ClinicalTrials.gov 2025-06-08